Investigation of V520 in a HIV Vaccine Dose Refinement Study (V520-027)(TERMINATED)
Clinical trial NCT00350623 · TERMINATED
Trial details
- NCT number
- NCT00350623
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2008-05-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.